Literature DB >> 12743361

Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia.

Isabelle Petitpas1, Charles E Petersen, Chung-Eun Ha, Ananyo A Bhattacharya, Patricia A Zunszain, Jamie Ghuman, Nadhipuram V Bhagavan, Stephen Curry.   

Abstract

Human serum albumin (HSA) is the major protein component of blood plasma and serves as a transporter for thyroxine and other hydrophobic compounds such as fatty acids and bilirubin. We report here a structural characterization of HSA-thyroxine interactions. Using crystallographic analyses we have identified four binding sites for thyroxine on HSA distributed in subdomains IIA, IIIA, and IIIB. Mutation of residue R218 within subdomain IIA greatly enhances the affinity for thyroxine and causes the elevated serum thyroxine levels associated with familial dysalbuminemic hyperthyroxinemia (FDH). Structural analysis of two FDH mutants of HSA (R218H and R218P) shows that this effect arises because substitution of R218, which contacts the hormone bound in subdomain IIA, produces localized conformational changes to relax steric restrictions on thyroxine binding at this site. We have also found that, although fatty acid binding competes with thyroxine at all four sites, it induces conformational changes that create a fifth hormone-binding site in the cleft between domains I and III, at least 9 A from R218. These structural observations are consistent with binding data showing that HSA retains a high-affinity site for thyroxine in the presence of excess fatty acid that is insensitive to FDH mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743361      PMCID: PMC164465          DOI: 10.1073/pnas.1137188100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Expression of a human serum albumin fragment (consisting of subdomains IA, IB, and IIA) and a study of its properties.

Authors:  D S Park; C E Petersen; C Ha; K Harohalli; J B Feix; N V Bhagavan
Journal:  IUBMB Life       Date:  1999-08       Impact factor: 3.885

2.  A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.

Authors:  N Wada; H Chiba; C Shimizu; H Kijima; M Kubo; T Koike
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

3.  Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor?

Authors:  C C Blake; S J Oatley
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

4.  Familial dysalbuminaemic hyperthyroxinaemia.

Authors:  S J Fleming; G F Applegate; C G Beardwell
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

5.  Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.

Authors:  H Vorum; B Honoré
Journal:  J Pharm Pharmacol       Date:  1996-08       Impact factor: 3.765

6.  Crystal structure of human serum albumin at 2.5 A resolution.

Authors:  S Sugio; A Kashima; S Mochizuki; M Noda; K Kobayashi
Journal:  Protein Eng       Date:  1999-06

7.  Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.

Authors:  I Petitpas; A A Bhattacharya; S Twine; M East; S Curry
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

8.  An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families.

Authors:  T Sunthornthepvarakul; P Angkeow; R E Weiss; Y Hayashi; S Refetoff
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

9.  A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.

Authors:  C E Petersen; A G Scottolini; L R Cody; M Mandel; N Reimer; N V Bhagavan
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

10.  Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia.

Authors:  C M Divino; G C Schussler
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

View more
  52 in total

1.  Structural mechanism for the carriage and release of thyroxine in the blood.

Authors:  Aiwu Zhou; Zhenquan Wei; Randy J Read; Robin W Carrell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

2.  Translational and rotational motions of albumin sensed by a non-covalent associated porphyrin under physiological and acidic conditions: a fluorescence correlation spectroscopy and time resolved anisotropy study.

Authors:  Suzana M Andrade; Silvia M B Costa; Jan Willem Borst; Arie van Hoek; Antonie J W G Visser
Journal:  J Fluoresc       Date:  2008-02-09       Impact factor: 2.217

3.  A Plasma Protein Network Regulates PM20D1 and N-Acyl Amino Acid Bioactivity.

Authors:  Joon T Kim; Mark P Jedrychowski; Wei Wei; Daniel Fernandez; Curt R Fischer; Steven M Banik; Bruce M Spiegelman; Jonathan Z Long
Journal:  Cell Chem Biol       Date:  2020-05-12       Impact factor: 8.116

4.  Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.

Authors:  J R Simard; P A Zunszain; C-E Ha; J S Yang; N V Bhagavan; I Petitpas; S Curry; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

5.  Characterization of the solution structure of human serum albumin loaded with a metal porphyrin and fatty acids.

Authors:  Matthias J N Junk; Hans W Spiess; Dariush Hinderberger
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

6.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

7.  Structural mechanism of ring-opening reaction of glucose by human serum albumin.

Authors:  Yu Wang; Haiyang Yu; Xiaoli Shi; Zhipu Luo; Donghai Lin; Mingdong Huang
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

8.  Protective effect of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraiodothyroacetic acids on serum albumin fibrillation.

Authors:  Leonardo M Cortez; Ricardo N Farías; Rosana N Chehín
Journal:  Eur Biophys J       Date:  2009-04-18       Impact factor: 1.733

9.  Influence of stearic acids on resveratrol-HSA interaction.

Authors:  Manuela Pantusa; Luigi Sportelli; Rosa Bartucci
Journal:  Eur Biophys J       Date:  2012-09-18       Impact factor: 1.733

10.  Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.

Authors:  Paolo Ascenzi; Alessandra di Masi; Massimo Coletta; Chiara Ciaccio; Gabriella Fanali; Francesco P Nicoletti; Giulietta Smulevich; Mauro Fasano
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.